A Japanese prospective cohort study revealed that higher plant protein intake was associated with lower total and cardiovascular disease (CVD)-related mortality. The study included 70 696 participants aged 45 to 74 years (54.5% women) from January 1, 1995, through December 31, 1999, with follow-up completed December 31, 2016. Dietary intake information was collected through a validated food frequency questionnaire. Participants were grouped into quintile categories based on their protein intake. Intake of animal protein showed no clear association with total or cause-specific mortality. In contrast, intake of plant protein was associated with lower total mortality, with multivariable-adjusted hazard ratios (HRs) of 0.89, 0.88, 0.84 and 0.87 for quintile 2-5, respectively, with quintile 1 as the reference category. For cause-specific mortality, this association with plant protein intake was evident for CVD–related mortality. Isocaloric substitution of 3% energy from plant protein for red meat protein was associated with lower total (HR, 0.66), cancer-related (HR, 0.61), and CVD-related (HR, 0.58) mortality; substitution for processed meat protein was associated with lower total (HR, 0.54) and cancer-related (HR, 0.50) mortality. The findings are consistent with mounting evidence in health benefits of plant-based foods and suggest that a higher intake of plant-based proteins may contribute to long-term health and longevity. Source: https://jamanetwork.com/
A study revealed that stroke remains a major global health challenge, influenced by numerous risk…
A systematic review and meta-analysis evaluated randomized controlled trials on pharmacological treatments for anxiety in…
A global study suggested that most patients with coronary heart disease (CHD) have Lipoprotein (a)…
A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…
A Canadian study of adults with high blood pressure (BP) found no difference in health…
Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…
This website uses cookies.